Vycor Medical, Inc. (VYCO)

Market Cap	3.67M +14.9%
Revenue (ttm)	1.90M +31.9%
Net Income	-340.85K
EPS	-0.01
Shares Out	33.37M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Average Volume	16,138
Open	0.1100
Previous Close	0.1100
Day's Range	0.1100 - 0.1100
52-Week Range	0.0511 - 0.5000
Beta	-0.58
RSI	43.62
Earnings Date	Mar 27, 2026

About Vycor Medical

Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement with a ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 7
• Stock Exchange: OTCMKTS
• Ticker Symbol: VYCO

Financial Performance

In 2024, Vycor Medical's revenue was $1.59 million, an increase of 8.81% compared to the previous year's $1.46 million. Losses were -$431,570, 9.52% more than in 2023.